Patent ID: 6569467
Filing Date: 2003-05-27
Classification: A61K,A61M,A61P,Y10S

Abstract:
A process of treating a mammalian patient suffering from inflammatory bowel disease; to alleviate the symptoms thereof, which comprises:extracting an aliquot of blood from the patient; modifying the extracted blood aliquot extracorporeally by subjecting it to an immune systemâ€”modifying amount of ozone gas and ultraviolet radiation, so as to create in the blood aliquot, in comparison with an equal volume aliquot of said patient's unmodified blood, at least one of the following distinguishing features; (a) increased number of leucocytes exhibiting a condensed apoptotic-like morphology; (b) a reduction in the number of leucocytes expressed in the MHC class 2 leucocyte cell surface specific protein HLA-DR; (c) an up-regulated expression or leucocytes of the CD-11b cell surface marker; and reinjecting the blood aliquot so modified into the patient.